Abstract
Bone changes in thalassemic patients receiving deferoxamine therapy for iron chelation include metaphyseal and growth plate irregularities. We present a case of an 8-year-old female with thalassemia major, who had magnetic resonance imaging after plain radiographs had shown metaphyseal changes in the distal femur. The signal characteristics of these abnormalities were consistent with hyaline cartilage; the surrounding marrow showed no evidence of iorn overload.
Similar content being viewed by others
References
De Virgilis A, Congia M, Fran F et al (1988) Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr 113:661–669
Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S (1991) Deferoxamine-induced bone dysplasia in patients with thalassemia major. AJR 156:561–565
Orzincolo C, Scutellari PN, Castaldi G (1992) Growth plate injury of the long bones in treated β-Thalassemia. Skeletal Radiol 21:39–44
Olivieri NF, Koren G, Harris J et al. (1992) Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 14:48–56
Harcke HT, Synder M, Caro PA, Bowen JR (1992) Growth plate of the normal knee: evaluation with MR imaging. Radiology 183:119–123
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, T.T., Caldwell, G., Kaye, J.J. et al. MR imaging of deferoxamine-induced bone dysplasia in an 8-year-old female with thalassemia major. Pediatr Radiol 23, 523–524 (1993). https://doi.org/10.1007/BF02012138
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02012138